Home Cart 0 Sign in  
X

[ CAS No. 1201-93-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 1201-93-0
Chemical Structure| 1201-93-0
Chemical Structure| 1201-93-0
Structure of 1201-93-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1201-93-0 ]

Related Doc. of [ 1201-93-0 ]

Alternatived Products of [ 1201-93-0 ]

Product Details of [ 1201-93-0 ]

CAS No. :1201-93-0 MDL No. :MFCD00121193
Formula : C11H13NO Boiling Point : -
Linear Structure Formula :- InChI Key :HUTKDPINCSJXAA-CMDGGOBGSA-N
M.W : 175.23 Pubchem ID :5398495
Synonyms :

Calculated chemistry of [ 1201-93-0 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.18
Num. rotatable bonds : 3
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 53.48
TPSA : 20.31 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.86 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.21
Log Po/w (XLOGP3) : 2.13
Log Po/w (WLOGP) : 1.94
Log Po/w (MLOGP) : 1.68
Log Po/w (SILICOS-IT) : 1.8
Consensus Log Po/w : 1.95

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.41
Solubility : 0.679 mg/ml ; 0.00387 mol/l
Class : Soluble
Log S (Ali) : -2.19
Solubility : 1.14 mg/ml ; 0.00649 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.54
Solubility : 0.502 mg/ml ; 0.00286 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.98

Safety of [ 1201-93-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1201-93-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1201-93-0 ]
  • Downstream synthetic route of [ 1201-93-0 ]

[ 1201-93-0 ] Synthesis Path-Upstream   1~21

  • 1
  • [ 4637-24-5 ]
  • [ 98-86-2 ]
  • [ 1201-93-0 ]
YieldReaction ConditionsOperation in experiment
97% at 140℃; for 12 h; In a 100 mL dry round bottom flask, acetophenone 1.08 g (9 mmol) of N,N-Dimethylformamide dimethyl acetal 3.9 mL (30 mmol) and 30 mL of xylene were added as a solvent. The mixture was refluxed at 140 ° C for 12 hours. After the TLC detection reaction was completed, the heating was stopped, the solvent was removed under reduced pressure, and the crude product was separated by flash column chromatography to give a pale yellow solid N,N-(dimethylamino)-1-phenyl enaminoketones 1.48 g (97percent yield).
92% Reflux 2-1 1: Preparation of 3-dimethylamino-1- Yield: 92percent. Appearance: yellow solid. phenylprop-2-en-1-one (Protocol SA and 1H NMR: 2.93-3.14 (m, 6H); 5.73 (d, 1H, PC) J = 12.4 Hz); 7.38-7.49 (m, 3H); 7.82 (d, 1H, J = 12.4 Hz); 7.89 (d, 2H, J = 7.9 Hz).; Protocol SA:The appropriate ketone (acetophenone for Ex. 2-1; 4-trifluoroacetophenone for Ex. 2-2; 2-phenylacetophenone for Ex. 2-3; 2-acetylfuran for Ex. 2-5; para-acetylbiphenyl for Example 2-6; 3-trifluoromethylacetophenone 2.7) is dissolved in dimethyl acetal of N,N-dimethylformamide (1.2 to 1.5 eq.). The reaction mixture is stirred under reflux. The estimated reaction time varies between 24 and 48 hours. Satisfactory results were obtained in 24 hours.
83% at 115℃; for 20 h; To a 100 mL round bottom flask, was added acetophenone (1.0 g, 0.0083 mol) followed by NN-dimethylformamide dimethyl acetal (1.48 g, 0.012 mol). The reaction mixture was stirred at 115 °C for 20 h. The reaction mixture was cooled to room temperature and ether was added to get the solid. The solid was collected by filtration to get the title compound [1.2 g, 83 percent]. JH NMR (300 MHz, CDC13): δ 7.89-7.86 (m, 2H), 7.80 (d, = 12.3 Hz, 1H), 7.44-7.39 (m, 3H), 5.72 (d, = 12.6 Hz, 1H), 3.11 (s, 3H), 2.91 (s, 3H); LC-MS: 176.0 [M+H]+.
82% at 150℃; for 20 h; Inert atmosphere A mixture of acetophenone 1 (5.0 g, 41.66 mmol) and DMF-DMA (17.71 mL, 49.9 mmol) in DMF (10 mL) was heated to 150 0C under N2 atmosphere. After stirring for 2Oh at 150 0C, the reaction mixture was concentrated in vacuo. The resulting residue was triturated with diethyl ether, filtered and dried under high vacuum to obtain compound 2 (6 g, 82percent) as a yellow solid. TLC Rf = 0.5 (CHCl3 - MeOH, 7:3); 1H NMR (CDCl3) δ 7.88 (dd, J= 7.8, 1.5 Hz, 2H), 7.8 (d, J= 12.3 Hz, IH), 7.42 (m, 3H), 5.71 (d, J= 12.3 Hz, IH), 3.1 (s, 6H); MS (ES) mlz 176 (M + H)+.
82% at 150℃; for 20 h; Inert atmosphere General procedure: A mixture of acetophenone 7a-7d (41.66 mmol) and DMF-DMA (49.9 mmol) in DMF (10 mL) was heated to 150 oC under N2 atmosphere. After being stirred for 20h at this temperature, the reaction mixture was concentrated in vacuo and the residue obtained was triturated with diethyl ether, filtered and dried under high vacuum to obtain compound 2a-2d (70-85percent) as a yellow solid.
81% for 14 h; Reflux General procedure: To a mixture of acetone 14b (5.8 g, 100 mmol), inxylene (200 mL), was added dimethylformamide dimethylacetal (DMF-DMA, 11.9 g, 100 mmol)and the reaction refluxed for 15 h (monitored by TLC). The xylene was distilled off and the resultingsolid residue was purified by column chromatography using PE and EtOAc (6:1) as eluent to afford4-(dimethylamino)but-3-en-2-one 15b (4.3 g, 38percent) as a yellow oil.
62% for 21 h; Reflux 5 g of acetophenone, 15 g of N, N-dimethylformamide dimethylacetal, and 60 ml of xylene were refluxed overnight (21 hours), a little raw material was not reacted and the reaction was stopped.
The reaction solution was cooled and concentrated to remove xylene.
150 ml of petroleum ether was added to the residue, and a solid precipitated under stirring, followed by filtration to obtain 4.5 g of 3-dimethylamino-1-phenyl-prop-2-en-1-one as a yellow solid, 62percent.

Reference: [1] RSC Advances, 2017, vol. 7, # 45, p. 28483 - 28488
[2] Patent: CN108383763, 2018, A, . Location in patent: Paragraph 0044; 0046
[3] Patent: US2011/195993, 2011, A1, . Location in patent: Page/Page column 10; 14
[4] Journal of Organic Chemistry, 1980, vol. 45, # 24, p. 4857 - 4860
[5] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 4, p. 1214 - 1217
[6] Organic Process Research and Development, 2008, vol. 12, # 3, p. 490 - 495
[7] Patent: WO2014/125426, 2014, A1, . Location in patent: Page/Page column 54; 55
[8] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 20, p. 5609 - 5613
[9] Patent: WO2010/129049, 2010, A1, . Location in patent: Page/Page column 114; 118
[10] Bioorganic and Medicinal Chemistry Letters, 2011, vol. 21, # 15, p. 4528 - 4532
[11] Chemical Communications, 2016, vol. 52, # 83, p. 12306 - 12309
[12] Molecules, 2017, vol. 22, # 12,
[13] Patent: WO2006/123648, 2006, A1, . Location in patent: Page/Page column 20
[14] Journal of Heterocyclic Chemistry, 1996, vol. 33, # 6, p. 1707 - 1710
[15] Bioorganic and Medicinal Chemistry, 2011, vol. 19, # 8, p. 2742 - 2750
[16] Patent: EP3287456, 2018, A1, . Location in patent: Paragraph 0175
[17] Journal of Heterocyclic Chemistry, 1987, vol. 24, p. 837 - 843
[18] Journal of the Chinese Chemical Society, 2003, vol. 50, # 2, p. 283 - 296
[19] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 18, p. 3055 - 3057
[20] Journal of the American Chemical Society, 2010, vol. 132, # 44, p. 15531 - 15533
[21] Journal of the Indian Chemical Society, 2010, vol. 87, # 6, p. 739 - 742
[22] ACS Combinatorial Science, 2011, vol. 13, # 4, p. 427 - 435
[23] Synthetic Communications, 2012, vol. 42, # 10, p. 1521 - 1531
[24] Tetrahedron, 2012, vol. 68, # 25, p. 5046 - 5052
[25] Organic Letters, 2012, vol. 14, # 15, p. 3920 - 3923
[26] Tetrahedron Letters, 2013, vol. 54, # 21, p. 2612 - 2614
[27] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 6, p. 1581 - 1588
[28] Medicinal Chemistry Research, 2015, vol. 24, # 6, p. 2742 - 2755
[29] Synthetic Communications, 2015, vol. 45, # 16, p. 1902 - 1911
[30] Journal of Heterocyclic Chemistry, 2015, vol. 52, # 5, p. 1296 - 1301
[31] Synthetic Communications, 2015, vol. 45, # 23, p. 2683 - 2690
[32] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 8, p. 1749 - 1756
[33] New Journal of Chemistry, 2016, vol. 40, # 5, p. 4705 - 4709
[34] Chemistry - A European Journal, 2016, vol. 22, # 29, p. 9966 - 9970
[35] Molecules, 2015, vol. 20, # 5, p. 8800 - 8815
[36] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 23, p. 6166 - 6173
[37] European Journal of Medicinal Chemistry, 2017, vol. 128, p. 1 - 12
[38] Letters in Organic Chemistry, 2017, vol. 14, # 5, p. 353 - 360
[39] European Journal of Medicinal Chemistry, 2018, vol. 155, p. 545 - 551
[40] European Journal of Medicinal Chemistry, 2018, vol. 152, p. 307 - 317
[41] Patent: WO2018/142365, 2018, A1, . Location in patent: Page/Page column 66
[42] Bioorganic Chemistry, 2019, vol. 83, p. 549 - 558
[43] Chemical Communications, 2018, vol. 54, # 99, p. 13953 - 13956
  • 2
  • [ 75-52-5 ]
  • [ 124-40-3 ]
  • [ 98-86-2 ]
  • [ 1201-93-0 ]
Reference: [1] Chemical Communications, 2015, vol. 51, # 55, p. 11108 - 11111
  • 3
  • [ 14677-24-8 ]
  • [ 124-40-3 ]
  • [ 1201-93-0 ]
Reference: [1] Research on Chemical Intermediates, 2017, vol. 43, # 10, p. 5547 - 5555
  • 4
  • [ 220436-00-0 ]
  • [ 1201-93-0 ]
Reference: [1] Organic Letters, 2014, vol. 16, # 16, p. 4146 - 4149
  • 5
  • [ 3506-36-3 ]
  • [ 1201-93-0 ]
Reference: [1] Chemical Communications, 2016, vol. 52, # 99, p. 14314 - 14317
  • 6
  • [ 20353-93-9 ]
  • [ 98-86-2 ]
  • [ 1201-93-0 ]
Reference: [1] Letters in Organic Chemistry, 2010, vol. 7, # 6, p. 483 - 486
  • 7
  • [ 70769-76-5 ]
  • [ 124-40-3 ]
  • [ 1201-93-0 ]
Reference: [1] Synthesis, 1980, # 5, p. 390 - 392
  • 8
  • [ 1794-48-5 ]
  • [ 1201-93-0 ]
Reference: [1] Organic Letters, 2014, vol. 16, # 16, p. 4146 - 4149
  • 9
  • [ 68-12-2 ]
  • [ 98-86-2 ]
  • [ 1201-93-0 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2010, vol. 20, # 12, p. 3821 - 3825
[2] RSC Advances, 2013, vol. 3, # 26, p. 10251 - 10261
[3] Journal of Organic Chemistry, 2015, vol. 80, # 9, p. 4722 - 4728
  • 10
  • [ 74896-59-6 ]
  • [ 1201-93-0 ]
Reference: [1] Synthesis, 1980, # 5, p. 390 - 392
  • 11
  • [ 98-86-2 ]
  • [ 1201-93-0 ]
Reference: [1] Bulletin des Societes Chimiques Belges, 1994, vol. 103, # 12, p. 697 - 704
  • 12
  • [ 24301-15-3 ]
  • [ 1201-93-0 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1980, vol. 17, p. 405 - 406
  • 13
  • [ 3306-07-8 ]
  • [ 1201-93-0 ]
Reference: [1] Bulletin of the Academy of Sciences of the USSR, Division of Chemical Science (English Translation), 1966, p. 1704 - 1710[2] Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya, 1966, # 10, p. 1764 - 1772
  • 14
  • [ 98-86-2 ]
  • [ 1201-93-0 ]
Reference: [1] Collection of Czechoslovak Chemical Communications, 1960, vol. 25, p. 1302 - 1307
  • 15
  • [ 3506-51-2 ]
  • [ 124-40-3 ]
  • [ 1201-93-0 ]
Reference: [1] Bulletin de la Societe Chimique de France, 1965, p. 2328 - 2332
  • 16
  • [ 98-86-2 ]
  • [ 1188-33-6 ]
  • [ 1201-93-0 ]
Reference: [1] Chemische Berichte, 1964, vol. 97, p. 3397 - 3406
[2] Justus Liebigs Annalen der Chemie, 1961, vol. 641, p. 1 - 39
  • 17
  • [ 1186-70-5 ]
  • [ 98-86-2 ]
  • [ 1201-93-0 ]
Reference: [1] Chemische Berichte, 1964, vol. 97, p. 3397 - 3406
  • 18
  • [ 127-19-5 ]
  • [ 98-86-2 ]
  • [ 1201-93-0 ]
Reference: [1] Patent: WO2018/17874, 2018, A1, . Location in patent: Page/Page column 57
  • 19
  • [ 5780-17-6 ]
  • [ 98-86-2 ]
  • [ 1201-93-0 ]
Reference: [1] Bulletin of the Academy of Sciences of the USSR, Division of Chemical Science (English Translation), 1965, p. 2143 - 2149[2] Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya, 1965, p. 2179 - 2187
  • 20
  • [ 1201-93-0 ]
  • [ 85658-55-5 ]
Reference: [1] Patent: WO2014/125426, 2014, A1,
  • 21
  • [ 1201-93-0 ]
  • [ 74647-39-5 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2016, vol. 24, # 23, p. 6166 - 6173
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1201-93-0 ]

Aryls

Chemical Structure| 70504-01-7

[ 70504-01-7 ]

1-(6-(Dimethylamino)naphthalen-2-yl)propan-1-one

Similarity: 0.76

Chemical Structure| 2124-31-4

[ 2124-31-4 ]

1-(4-(Dimethylamino)phenyl)ethanone

Similarity: 0.74

Chemical Structure| 2835-77-0

[ 2835-77-0 ]

2-Aminobenzophenone

Similarity: 0.74

Chemical Structure| 92-91-1

[ 92-91-1 ]

1-([1,1'-Biphenyl]-4-yl)ethanone

Similarity: 0.74

Chemical Structure| 787-69-9

[ 787-69-9 ]

4,4'-Diacetylbiphenyl

Similarity: 0.74

Alkenes

Chemical Structure| 614-47-1

[ 614-47-1 ]

(E)-1,3-Diphenylprop-2-en-1-one

Similarity: 0.74

Chemical Structure| 768-03-6

[ 768-03-6 ]

1-Phenylprop-2-en-1-one

Similarity: 0.74

Chemical Structure| 1227694-88-3

[ 1227694-88-3 ]

(E)-N-(3-(3-(Dimethylamino)acryloyl)phenyl)-N-methylacetamide

Similarity: 0.70

Chemical Structure| 96605-66-2

[ 96605-66-2 ]

N-(3-(3-(Dimethylamino)acryloyl)phenyl)-N-ethylacetamide

Similarity: 0.70

Chemical Structure| 115955-48-1

[ 115955-48-1 ]

3-(Dimethylamino)-1-(3-nitrophenyl)prop-2-en-1-one

Similarity: 0.67

Ketones

Chemical Structure| 70504-01-7

[ 70504-01-7 ]

1-(6-(Dimethylamino)naphthalen-2-yl)propan-1-one

Similarity: 0.76

Chemical Structure| 2124-31-4

[ 2124-31-4 ]

1-(4-(Dimethylamino)phenyl)ethanone

Similarity: 0.74

Chemical Structure| 2835-77-0

[ 2835-77-0 ]

2-Aminobenzophenone

Similarity: 0.74

Chemical Structure| 92-91-1

[ 92-91-1 ]

1-([1,1'-Biphenyl]-4-yl)ethanone

Similarity: 0.74

Chemical Structure| 787-69-9

[ 787-69-9 ]

4,4'-Diacetylbiphenyl

Similarity: 0.74

Amines

Chemical Structure| 70504-01-7

[ 70504-01-7 ]

1-(6-(Dimethylamino)naphthalen-2-yl)propan-1-one

Similarity: 0.76

Chemical Structure| 2124-31-4

[ 2124-31-4 ]

1-(4-(Dimethylamino)phenyl)ethanone

Similarity: 0.74

Chemical Structure| 2835-77-0

[ 2835-77-0 ]

2-Aminobenzophenone

Similarity: 0.74

Chemical Structure| 551-93-9

[ 551-93-9 ]

1-(2-Aminophenyl)ethanone

Similarity: 0.73

Chemical Structure| 122710-21-8

[ 122710-21-8 ]

1-(2-Amino-4-methylphenyl)ethanone

Similarity: 0.73